TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.71B
1-Year Return
19.93%
This Quarter Return
+8.37%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.84B
AUM Growth
-$2.1B
(-35%)
Cap. Flow
-$2.53B
Cap. Flow
% of AUM
-65.73%
Top 10 Holdings %
Top 10 Hldgs %
22.61%
Holding
6,382
New
829
Increased
1,885
Reduced
2,768
Closed
710
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$179M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$26.5M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$12.8M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$11.3M |
| 5 |
iShares Russell 3000 ETF
IWV
|
+$9.83M |
Top Sells
| 1 |
Apple
AAPL
|
+$127M |
| 2 |
Microsoft
MSFT
|
+$122M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$73.2M |
| 4 |
Amazon
AMZN
|
+$72.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$53.5M |
Sector Composition
| 1 | Technology | 19.08% |
| 2 | Consumer Discretionary | 11.67% |
| 3 | Healthcare | 9.59% |
| 4 | Financials | 9.24% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
BridgeBio Pharma
BBIO
$9.79B
| $326K | 0.01% |
5,347
-2,232
| -29% | -$136K |
|
1527
Canadian Pacific Kansas City
CP
$68.9B
| $326K | 0.01% |
4,244
-6,706
| -61% | -$515K |
|
1528
Castle Biosciences
CSTL
$621M
| $326K | 0.01% |
4,448
+606
| +16% | +$44.4K |
|
1529
Invesco S&P 500 Revenue ETF
RWL
$6.55B
| $326K | 0.01% |
4,427
+2,226
| +101% | +$164K |
|
1530
Shoals Technologies Group
SHLS
$1.15B
| $326K | 0.01% |
9,193
+6,949
| +310% | +$246K |
|
1531
SpartanNash
SPTN
$897M
| $325K | 0.01% |
16,836
+15,249
| +961% | +$294K |
|
1532
Vanguard Mega Cap 300 Index ETF
MGC
$7.84B
| $324K | 0.01% |
+2,125
| New | +$324K |
|
|
WPF
1533
DELISTED
Foley Trasimene Acquisition Corp.
WPF
| $324K | 0.01% |
+33,109
| New | +$324K |
|
1534
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.29B
| $324K | 0.01% |
14,449
-52,579
| -78% | -$1.18M |
|
|
KRTX
1535
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $324K | 0.01% |
2,842
+2,088
| +277% | +$238K |
|
1536
Apellis Pharmaceuticals
APLS
$3.14B
| $323K | 0.01% |
5,111
+1,662
| +48% | +$105K |
|
1537
Axalta
AXTA
$6.75B
| $323K | 0.01% |
10,591
+4,637
| +78% | +$141K |
|
1538
Franco-Nevada
FNV
$38.6B
| $323K | 0.01% |
+2,223
| New | +$323K |
|
1539
MSC Industrial Direct
MSM
$5.09B
| $323K | 0.01% |
3,595
-1,596
| -31% | -$143K |
|
1540
LiveRamp
RAMP
$1.73B
| $323K | 0.01% |
6,887
-2,229
| -24% | -$105K |
|
1541
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.86B
| $323K | 0.01% |
4,533
+2,242
| +98% | +$160K |
|
1542
ProShares UltraShort Financials
SKF
$9.98M
| $322K | 0.01% |
3,968
+3,076
| +345% | +$250K |
|
1543
Navient
NAVI
$1.28B
| $321K | 0.01% |
16,577
-3,986
| -19% | -$77.2K |
|
|
SRG
1544
Seritage Growth Properties
SRG
$237M
| $321K | 0.01% |
17,457
+14,843
| +568% | +$273K |
|
1545
Vanguard Small-Cap Growth ETF
VBK
$20.5B
| $321K | 0.01% |
1,110
+1,081
| +3,728% | +$313K |
|
1546
The Greenbrier Companies
GBX
$1.42B
| $321K | 0.01% |
7,355
+2,082
| +39% | +$90.9K |
|
1547
Schwab Fundamental US Broad Market Index ETF
FNDB
$993M
| $320K | 0.01% |
+17,649
| New | +$320K |
|
1548
OFG Bancorp
OFG
$1.95B
| $320K | 0.01% |
14,454
-2,615
| -15% | -$57.9K |
|
1549
PTC
PTC
$24.6B
| $320K | 0.01% |
2,263
-9,739
| -81% | -$1.38M |
|
1550
BioMarin Pharmaceuticals
BMRN
$10.4B
| $319K | 0.01% |
3,818
-19,047
| -83% | -$1.59M |
|